Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Allegra Medical Technologies stock

AMT.AX
AU000000AMT8
A0M7NQ

Price

0.03
Today +/-
+0
Today %
+0 %
P

Allegra Medical Technologies stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Allegra Medical Technologies stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Allegra Medical Technologies stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Allegra Medical Technologies stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Allegra Medical Technologies's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Allegra Medical Technologies Stock Price History

DateAllegra Medical Technologies Price
11/11/20240.03 undefined
11/8/20240.03 undefined
11/7/20240.03 undefined
11/6/20240.03 undefined
11/5/20240.03 undefined
11/4/20240.03 undefined
11/1/20240.03 undefined
10/31/20240.03 undefined
10/30/20240.03 undefined
10/29/20240.03 undefined
10/28/20240.03 undefined
10/25/20240.03 undefined
10/24/20240.03 undefined
10/23/20240.03 undefined
10/22/20240.03 undefined
10/21/20240.03 undefined
10/18/20240.03 undefined
10/17/20240.03 undefined
10/16/20240.03 undefined
10/15/20240.03 undefined
10/14/20240.03 undefined

Allegra Medical Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Allegra Medical Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Allegra Medical Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Allegra Medical Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Allegra Medical Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Allegra Medical Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Allegra Medical Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Allegra Medical Technologies’s growth potential.

Allegra Medical Technologies Revenue, EBIT and net profit per share

DateAllegra Medical Technologies RevenueAllegra Medical Technologies EBITAllegra Medical Technologies Net Income
2023130 undefined-1.79 M undefined-3.65 M undefined
202210 undefined-1.88 M undefined-2.54 M undefined
20214.5 M undefined-565,620 undefined-578,850 undefined
20205.02 M undefined-1.16 M undefined-1.17 M undefined
20194 M undefined-835,510 undefined-835,510 undefined
20184.69 M undefined-596,190 undefined-604,140 undefined
20174.94 M undefined612,340 undefined501,050 undefined
20165.02 M undefined-1.97 M undefined-2.04 M undefined
20157.33 M undefined-1.33 M undefined-855,060 undefined
20147.97 M undefined-70,000 undefined-60,000 undefined
20137.18 M undefined-890,000 undefined-570,000 undefined
20128.67 M undefined-110,000 undefined-170,000 undefined
20117.37 M undefined-2.76 M undefined-3.27 M undefined
20107.47 M undefined-540,000 undefined-900,000 undefined
20096.41 M undefined-1.54 M undefined-1.02 M undefined
20087.09 M undefined310,000 undefined180,000 undefined
20075.82 M undefined80,000 undefined-80,000 undefined
20065.64 M undefined440,000 undefined210,000 undefined
20055.56 M undefined640,000 undefined280,000 undefined

Allegra Medical Technologies Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2005200620072008200920102011201220132014201520162017201820192020202120222023
5557677877754435400
---40.00-14.2916.67-14.29-12.50---28.57-20.00--25.0066.67-20.00--
60.0060.0060.0057.1450.0057.1457.1462.5042.8657.1442.8640.0075.0075.0066.6740.0050.00--
3334344534323322200
0000-10-2000-1-1000-10-1-1
-----16.67--28.57----14.29-20.00----20.00---
0000-10-30000-2000-10-2-3
------------------50.00
39.7439.7439.7437.9738.7938.7938.7938.7942.2248.0861.1667.8875.6794.2599.5699.56104.37104.46104.46
-------------------
Details

Keystats

Revenue and Growth

The Allegra Medical Technologies Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Allegra Medical Technologies is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (k)GOODWILL (k)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (k)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
0.781.520.850.720.0200.290.031.081.151.851.611.080.760.360.210
1.661.891.090.960.91.591.222.292.071.631.031.151.161.431.271.21.14
40100006107200000000000
2.762.712.822.832.875.63.123.272.361.511.783.033.133.233.022.850
0.120.070.060.040.160.22.5700000.150.140.080.160.131.06
5.366.24.824.553.9587.925.595.514.294.665.945.515.54.824.382.2
3.84.174.454.163.683.162.572.121.530.480.571.150.971.060.70.580.32
00000000000000000
0020021022019012012000000000706
210280230300280260150210238.3158.87154.48242.06211.02179.65712.83541.25400.76
0005900000000000000
0.50.931.140.80.4600000.10.10.10.10.110.110.110
4.515.386.026.064.643.612.842.451.770.730.821.491.291.341.521.231.42
9.8711.5810.8410.618.5911.6110.768.047.285.035.487.436.796.856.345.613.62
                                 
5.559.048.988.928.868.829.69.610.4610.4612.3514.8714.8714.8815.3715.3715.37
00000000000000000
-170320-530-1,400-4,660-4,830-5,400-5,430-6,273.16-8,308.94-7,792.9-8,384.43-9,197.55-10,331.91-10,792.85-13,233.93-16,865.32
000-3050500000000008580
00000000000000000
5.389.368.457.494.254.044.24.174.192.154.566.485.674.544.572.99-1.5
0.730.420.260.270.453.240.551.662.371.680.680.830.821.641.210.911.05
03902903904009708400000051.992.39122.18198.69155.78
00.210.410.460.540.433.040.150.380.040.050.060.110.33000.06
000019018000000007.94103.12105.79156.14
2.760.710.270.910.460.71.141.570.221.080.1500.080.160.170.360.29
3.491.731.232.032.045.525.573.382.962.80.880.891.062.231.61.581.71
0.780.060.790.761.981.70.740.230.10.0400000.081.872.68
601202000000000000000
16032035034033034025026030.1339.1844.4955.4261.1474.682.0131.7220
10.51.161.12.312.040.990.490.130.080.040.060.060.070.171.92.7
4.492.232.393.134.357.566.563.873.092.880.920.951.132.31.773.484.41
9.8711.5910.8410.628.611.610.768.047.285.035.487.436.796.856.346.472.91
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Allegra Medical Technologies provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Allegra Medical Technologies's financial health and stability.

Assets

Allegra Medical Technologies's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Allegra Medical Technologies must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Allegra Medical Technologies after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Allegra Medical Technologies's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (k)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (k)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20072008200920102011201220132014201520162017201820192020202120222023
000000000000000-20
00000000000000000
00000000000000000
000000001,00000000000
00000000000000000
00000000000000000
00000000000000000
-1,0001,00000-1,0000001,00000-1,000-1,00000-1,0000
00-100000000-100000
00-100000000-100000
00000000000000000
00000000000000000
00000000-1,0000000001,0000
31000000101200000
30000000000200010
-----------------
00000000000000000
01,00000-1,0000000-1,0000-2,000-2,000-1,000-1,000-2,000-1,000
-2.070.08-0.98-0.19-1.670.020.21-0.421.21-0.88-0.23-2.74-1.11-0.32-0.48-1.97-0.81
00000000000000000

Allegra Medical Technologies stock margins

The Allegra Medical Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Allegra Medical Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Allegra Medical Technologies.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Allegra Medical Technologies's sales revenue. A higher gross margin percentage indicates that the Allegra Medical Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Allegra Medical Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Allegra Medical Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Allegra Medical Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Allegra Medical Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Allegra Medical Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Allegra Medical Technologies Margin History

Allegra Medical Technologies Gross marginAllegra Medical Technologies Profit marginAllegra Medical Technologies EBIT marginAllegra Medical Technologies Profit margin
2023-10,607.69 %-1.37 M %-2.81 M %
202253,100 %-18.81 M %-25.35 M %
202158.36 %-12.56 %-12.86 %
202057.87 %-23.03 %-23.23 %
201960.81 %-20.9 %-20.9 %
201869.95 %-12.71 %-12.88 %
201768.28 %12.39 %10.14 %
201658.92 %-39.2 %-40.57 %
201551.46 %-18.16 %-11.67 %
201459.1 %-0.88 %-0.75 %
201353.9 %-12.4 %-7.94 %
201259.4 %-1.27 %-1.96 %
201155.36 %-37.45 %-44.37 %
201054.62 %-7.23 %-12.05 %
200949.14 %-24.02 %-15.91 %
200858.67 %4.37 %2.54 %
200765.12 %1.37 %-1.37 %
200656.38 %7.8 %3.72 %
200561.15 %11.51 %5.04 %

Allegra Medical Technologies Stock Sales Revenue, EBIT, Earnings per Share

The Allegra Medical Technologies earnings per share therefore indicates how much revenue Allegra Medical Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Allegra Medical Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Allegra Medical Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Allegra Medical Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Allegra Medical Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Allegra Medical Technologies Revenue, EBIT and net profit per share

DateAllegra Medical Technologies Sales per ShareAllegra Medical Technologies EBIT per shareAllegra Medical Technologies Earnings per Share
20230 undefined-0.02 undefined-0.03 undefined
20220 undefined-0.02 undefined-0.02 undefined
20210.04 undefined-0.01 undefined-0.01 undefined
20200.05 undefined-0.01 undefined-0.01 undefined
20190.04 undefined-0.01 undefined-0.01 undefined
20180.05 undefined-0.01 undefined-0.01 undefined
20170.07 undefined0.01 undefined0.01 undefined
20160.07 undefined-0.03 undefined-0.03 undefined
20150.12 undefined-0.02 undefined-0.01 undefined
20140.17 undefined-0 undefined-0 undefined
20130.17 undefined-0.02 undefined-0.01 undefined
20120.22 undefined-0 undefined-0 undefined
20110.19 undefined-0.07 undefined-0.08 undefined
20100.19 undefined-0.01 undefined-0.02 undefined
20090.17 undefined-0.04 undefined-0.03 undefined
20080.19 undefined0.01 undefined0 undefined
20070.15 undefined0 undefined-0 undefined
20060.14 undefined0.01 undefined0.01 undefined
20050.14 undefined0.02 undefined0.01 undefined

Allegra Medical Technologies business model

As an Australian company, Allegra Orthopaedics Ltd was founded in 2007 and has since achieved an impressive track record in the manufacturing and distribution of high-quality orthopedic products. The company focuses on the areas of traumatology, spinal surgery, and joint surgery, and aims to develop innovative solutions for the needs of doctors and patients. The business model of Allegra Orthopaedics Ltd is centered around collaboration with a variety of industry partners. Through close relationships with medical professionals, clinicians, and researchers, the company is able to identify the latest technologies and procedures and help develop high-quality products and services. In addition, Allegra Orthopaedics Ltd has established strategic partnerships with other companies in the orthopedic industry to leverage synergies and unlock growth potential. The company has various divisions that focus on specific areas of orthopedics. One of these is traumatology, which emphasizes the treatment of bone fractures and injuries. Here, Allegra Orthopaedics Ltd offers a wide range of products, including implants, surgical instruments, and supplies. Key products offered in the field of traumatology include intramedullary nails, bone screws, and plates. Another important area of the company is spinal surgery. Allegra Orthopaedics Ltd offers innovative solutions for the treatment of spinal injuries and conditions. The product range includes screws, plates, and hooks, all aimed at preserving or improving the structure and alignment of the spine. Joint surgery is another segment that Allegra Orthopaedics Ltd focuses on. In this area, the company develops solutions for the treatment of joint injuries and diseases such as arthritis. This includes artificial joints and instruments that allow for precise intervention in the affected joint. One of the renowned products of Allegra Orthopaedics Ltd is the Polyaxial Pedicle Screw System. This advanced system allows for more precise and effective stabilization of the spine in cases of injuries and diseases. The company has also developed a variety of products tailored to the needs of athletes and other active individuals, including ACL prostheses for cruciate ligament injuries. Overall, Allegra Orthopaedics Ltd has gained a high reputation in the orthopedic industry. The company is known for its innovative products based on the needs of patients and medical professionals worldwide. It has also built a strong presence in international markets and provides excellent customer experience with fast customer support, training, and technical services. Allegra Medical Technologies is one of the most popular companies on Eulerpool.com.

Allegra Medical Technologies SWOT Analysis

Strengths

Allegra Orthopaedics Ltd has a strong reputation in the market for producing high-quality orthopaedic products. The company's products are recognized for their superior design, durability, and effectiveness in addressing various orthopaedic issues.

Allegra Orthopaedics Ltd has a robust research and development (R&D) team that continuously innovates and enhances its product line. This gives the company a competitive edge by staying ahead of market trends and meeting the evolving needs of customers.

The company has established strong relationships with key healthcare professionals, including surgeons, hospitals, and medical practitioners. These relationships enable Allegra Orthopaedics Ltd to gain valuable insights, collaborate on product development, and drive sales through referrals and recommendations.

Weaknesses

One of the weaknesses of Allegra Orthopaedics Ltd is its limited geographical presence. The company's operations are currently concentrated in a few regions, which restricts its market reach and growth opportunities. Expanding into new markets can be a challenge due to regulatory complexities and the need to establish local distribution networks.

Allegra Orthopaedics Ltd is not as well-known compared to some of its larger competitors. Limited brand awareness may hinder its ability to attract new customers and gain market share, especially in highly competitive markets.

The company's heavy reliance on third-party suppliers for raw materials and components poses a risk to its supply chain. Any disruptions or quality issues with suppliers can negatively impact production and lead to delays in product delivery.

Opportunities

The growing aging population worldwide presents a significant opportunity for Allegra Orthopaedics Ltd. As the elderly population increases, there will be a higher demand for orthopaedic products and surgical procedures. By targeting this demographic, the company can potentially tap into a large and growing market segment.

Expanding into emerging markets, such as Asia-Pacific and Latin America, can provide Allegra Orthopaedics Ltd with new growth opportunities. These regions have a rising demand for advanced orthopaedic solutions, and entering these markets early can establish a strong foothold and access a large customer base.

Technological advancements in orthopaedics, such as robotics-assisted surgery and 3D-printed implants, present opportunities for Allegra Orthopaedics Ltd to develop innovative products and stay at the forefront of the industry. Embracing these advancements can differentiate the company and attract tech-savvy customers.

Threats

Intense competition from established orthopaedic companies poses a threat to Allegra Orthopaedics Ltd. Competitors with greater financial resources and market presence can outspend on marketing, research, and development, which may put pressure on the company's market share.

Regulatory challenges and compliance requirements in the healthcare industry can pose risks to Allegra Orthopaedics Ltd. Changing regulations, product approvals, and compliance with quality standards can increase costs and delay product launches.

External factors, such as economic downturns or global pandemics, can impact the demand for orthopaedic products and affect the company's financial performance. Uncertainties in the healthcare industry and reimbursement policies can create instability in the market and affect Allegra Orthopaedics Ltd's revenue streams.

Allegra Medical Technologies Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Allegra Medical Technologies historical P/E ratio, EBIT multiple, and P/S ratio

Allegra Medical Technologies shares outstanding

The number of shares was Allegra Medical Technologies in 2023 — This indicates how many shares 104.459 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Allegra Medical Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Allegra Medical Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Allegra Medical Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Allegra Medical Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Allegra Medical Technologies.

Allegra Medical Technologies shareholders

%
Name
Stocks
Change
Date
79.81639 % Hartnell (Nicholas J)95,468,37927,350,6387/29/2024
7.89847 % Netwealth Investments Ltd.9,447,35608/22/2023
6.03071 % CLJE Investments Pty. Ltd.7,213,33308/22/2023
5.51793 % Welsh Superannuation Pty. Ltd.6,600,00008/22/2023
4.71222 % Caroll (Marie)5,636,28508/22/2023
4.70311 % Leicester (Andrew William)5,625,39308/22/2023
4.01806 % University of Sydney4,806,00008/22/2023
2.50815 % 4 Holes-In-One Pty. Ltd.3,000,00008/22/2023
2.50815 % Dugal Diagnostics Pty. Ltd.3,000,00008/22/2023
1.39641 % CLJE Superannuation Fund1,670,24608/22/2023
1
2

Allegra Medical Technologies Executives and Management Board

Ms. Jenny Swain
Allegra Medical Technologies Chief Executive Officer
Compensation 345,423
Mr. Peter Kazacos
Allegra Medical Technologies Independent Non-Executive Chairman of the Board
Compensation 62,793
Mr. Sean Mulhearn
Allegra Medical Technologies Non-Executive Independent Director
Compensation 45,273
Dr. Nicholas Hartnell
Allegra Medical Technologies Non-Executive Director
Compensation 45,000
Ms. Robyn Slaughter
Allegra Medical Technologies Company Secretary
1

Allegra Medical Technologies Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer-0,65-0,590,100,670,36
1

Most common questions regarding Allegra Medical Technologies

What values and corporate philosophy does Allegra Medical Technologies represent?

Allegra Orthopaedics Ltd represents a strong commitment to providing innovative orthopaedic solutions. The company's corporate philosophy revolves around delivering superior patient outcomes, fostering collaborative partnerships, and embracing technological advancements in orthopaedic care. With a focus on research and development, Allegra Orthopaedics strives to introduce cutting-edge products and surgical techniques that enhance patient mobility and quality of life. As a leader in the orthopaedic industry, Allegra Orthopaedics is dedicated to maintaining the highest standards of integrity, professionalism, and customer satisfaction.

In which countries and regions is Allegra Medical Technologies primarily present?

Allegra Orthopaedics Ltd is primarily present in Australia and New Zealand.

What significant milestones has the company Allegra Medical Technologies achieved?

Allegra Orthopaedics Ltd has achieved several significant milestones since its establishment. The company has successfully developed and launched innovative orthopedic solutions, providing efficient and reliable treatments for various musculoskeletal conditions. Additionally, Allegra Orthopaedics Ltd has gained regulatory approvals and certifications for its products, ensuring their quality and safety. The company has also established strategic partnerships and collaborations with renowned healthcare institutions, enabling it to expand its market reach and enhance its research and development capabilities. Furthermore, Allegra Orthopaedics Ltd has achieved remarkable financial growth and recognition within the orthopedic industry, solidifying its position as a leading provider of orthopedic solutions.

What is the history and background of the company Allegra Medical Technologies?

Allegra Orthopaedics Ltd is an Australian-based company specializing in the design, development, and distribution of innovative orthopedic implant solutions. Established in 2014, Allegra Orthopaedics focuses on developing implants that provide better patient outcomes and improve surgical techniques. The company's commitment to research and development has led to the introduction of innovative products tailored to the needs of surgeons and patients. With a team of experienced professionals and strategic partnerships, Allegra Orthopaedics aims to improve the quality of life for individuals requiring orthopedic interventions.

Who are the main competitors of Allegra Medical Technologies in the market?

The main competitors of Allegra Orthopaedics Ltd in the market include established orthopedic companies such as Johnson & Johnson's DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings Inc., and Medtronic plc. These companies also specialize in manufacturing and supplying orthopedic devices and implants.

In which industries is Allegra Medical Technologies primarily active?

Allegra Orthopaedics Ltd is primarily active in the healthcare industry, specifically specializing in the field of orthopedics.

What is the business model of Allegra Medical Technologies?

The business model of Allegra Orthopaedics Ltd revolves around developing and commercializing innovative orthopedic implants and surgical instruments. With a focus on the extremities market, the company aims to provide solutions for a wide range of orthopedic conditions and injuries. Allegra Orthopaedics leverages its expertise in research and development to design and manufacture high-quality, patient-specific implants that offer improved surgical outcomes. By collaborating with surgeons and healthcare professionals, the company strives to address unmet needs in the orthopedic industry and enhance patient care. Allegra Orthopaedics Ltd is dedicated to delivering innovative orthopedic solutions, contributing to the advancement of orthopedic surgery.

What is the P/E ratio of Allegra Medical Technologies 2024?

The P/E ratio cannot be calculated for Allegra Medical Technologies at the moment.

What is the P/S ratio of Allegra Medical Technologies 2024?

The P/S cannot be calculated for Allegra Medical Technologies currently.

What is the Quality Investing of Allegra Medical Technologies?

The Quality Investing for Allegra Medical Technologies is 4/10.

What is the revenue of Allegra Medical Technologies 2024?

The revenue cannot currently be calculated for Allegra Medical Technologies.

How high is the profit of Allegra Medical Technologies 2024?

The profit cannot currently be calculated for Allegra Medical Technologies.

What is the business model of Allegra Medical Technologies

The company Allegra Orthopaedics Ltd is a medical company specializing in the development, manufacturing, and distribution of innovative orthopedic implants. Its goal is to improve the quality of life for patients by offering top-notch solutions for orthopedic problems. The company is headquartered in Australia and operates in other countries such as the USA, Europe, and Asia.

What is the Allegra Medical Technologies dividend?

Allegra Medical Technologies pays a dividend of 0 AUD distributed over payouts per year.

How often does Allegra Medical Technologies pay dividends?

The dividend cannot currently be calculated for Allegra Medical Technologies or the company does not pay out a dividend.

What is the Allegra Medical Technologies ISIN?

The ISIN of Allegra Medical Technologies is AU000000AMT8.

What is the Allegra Medical Technologies WKN?

The WKN of Allegra Medical Technologies is A0M7NQ.

What is the Allegra Medical Technologies ticker?

The ticker of Allegra Medical Technologies is AMT.AX.

How much dividend does Allegra Medical Technologies pay?

Over the past 12 months, Allegra Medical Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Allegra Medical Technologies is expected to pay a dividend of 0 AUD.

What is the dividend yield of Allegra Medical Technologies?

The current dividend yield of Allegra Medical Technologies is .

When does Allegra Medical Technologies pay dividends?

Allegra Medical Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Allegra Medical Technologies?

Allegra Medical Technologies paid dividends every year for the past 0 years.

What is the dividend of Allegra Medical Technologies?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Allegra Medical Technologies located?

Allegra Medical Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Allegra Medical Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Allegra Medical Technologies from 11/12/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/12/2024.

When did Allegra Medical Technologies pay the last dividend?

The last dividend was paid out on 11/12/2024.

What was the dividend of Allegra Medical Technologies in the year 2023?

In the year 2023, Allegra Medical Technologies distributed 0 AUD as dividends.

In which currency does Allegra Medical Technologies pay out the dividend?

The dividends of Allegra Medical Technologies are distributed in AUD.

All fundamentals about Allegra Medical Technologies

Our stock analysis for Allegra Medical Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Allegra Medical Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.